FDG PET/CT Findings in Abdominal Fat Necrosis After Treatment for Lymphoma

Clinical Nuclear Medicine
Julien DubreuilFrancesco Giammarile

Abstract

FDG PET/CT is now validated in non-Hodgkin lymphoma for response assessment in interim and posttreatment lymphoma. We report the case of a 62-year-old man followed by FDG PET/CT for a diffuse large B-cell lymphoma, with initial stage III. The interim FDG PET/CT examination concluded in complete metabolic and morphological response of subdiaphragmatic lymphadenopathy but a persistent abnormal subdiaphragmatic uptake (SUVmax at 9 and Deauville 5-point scale at 5). Therefore, an abdominal biopsy of the corresponding nodules was conducted with a final diagnosis of diffuse fat necrosis.

References

Mar 22, 2008·Clinical Nuclear Medicine·Abdelfatihe BelakhlefSuresh Lakhanpal
Aug 9, 2012·Revista española de medicina nuclear e imagen molecular·Burcu E Akkas, G Ucmak Vural
May 9, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Raghava KashyapMichael S Hofman
Oct 18, 2013·British Journal of Haematology·Sally Fiona Barrington, Nabegh George Mikhaeel
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonT Andrew Lister
Dec 3, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Ronald BoellaardUNKNOWN European Association of Nuclear Medicine (EANM)
Feb 7, 2015·Cancer Treatment and Research·Tarec Christoffer El-Galaly, Martin Hutchings
Mar 4, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marius E MayerhoeferMarkus Raderer
Jul 18, 2015·American Journal of Clinical Pathology·M Herman ChuiJan Delabie

❮ Previous
Next ❯

Citations

Jun 2, 2017·Nuclear Medicine Communications·Julien DubreuilAndrea Skanjeti
Dec 21, 2016·Clinical Nuclear Medicine·Julien DubreuilAndrea Skanjeti
Dec 22, 2017·European Radiology·Tima DavidsonBar Chikman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Mohammad Vaseemuddin, Ramin Sam
© 2021 Meta ULC. All rights reserved